After admission, the tumor markers were retested, with a serum pro-GRP level of 100.1 ng/mL, significantly elevated compared to 60.5 ng/mL 1 month ago (reference range: 0–70 ng/mL). The gene discussed is GRP; the disease is neoplasm.